SCHEMBL20767964

SCHEMBL20767964

Oc1cccc2nc(N3CCNCC3)sc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN4A P35499 2/20 0.46
SCN9A Q15858 2/20 0.46
KDM4E B2RXH2 3/20 0.45
HTR3A P46098 3/20 0.42
ALDH1A1 P00352 3/20 0.42
ADRB1 P08588 3/20 0.42
CYP3A4 P08684 2/20 0.42
HTR6 P50406 2/20 0.42
HSD17B10 Q99714 2/20 0.42
HTR3E A5X5Y0 2/20 0.42
HTR3B O95264 2/20 0.42
HTR3D Q70Z44 2/20 0.42
HTR3C Q8WXA8 2/20 0.42
USP2 O75604 1/20 0.42
CYP1A2 P05177 1/20 0.42
HTR1A P08908 1/20 0.42
HTR2C P28335 1/20 0.42
MAPK1 P28482 1/20 0.42
SLC6A4 P31645 1/20 0.42
HTR7 P34969 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8512161 0.84 ALDH1A1 (0.47) SCN4ASCN9AKDM4EHTR3AALDH1A1
SCHEMBL20767958 0.84 NAAA (0.48) SCN4ASCN9AKDM4EHTR3AALDH1A1
SCHEMBL3468625 0.82 KMT2A (0.45) KDM4EHTR3AALDH1A1HSD17B10HTR3E
SCHEMBL8050601 0.82 SMN1; SMN2 (0.61) ALDH1A1HSD17B10USP2HTTNPC1
SCHEMBL20767872 0.80 SCN4A (0.48) SCN4ASCN9AKDM4EHTR3AALDH1A1
SCHEMBL20767897 0.78 KDM4E (0.53) SCN4ASCN9AKDM4EALDH1A1CYP3A4
SCHEMBL5015061 0.78 SMN1; SMN2 (0.51) SCN4ASCN9AKDM4EALDH1A1NPC1
Hydrochloric Acid SCHEMBL4060481 0.77 SMN1; SMN2 (0.50) SCN4ASCN9AKDM4EALDH1A1NPC1
SCHEMBL232915 0.76 RAB9A (0.67) SCN4ASCN9AALDH1A1CYP1A2TDP1
SCHEMBL2096693 0.76 CHEK2 (0.46) KDM4ECYP1A2NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10221168-B1 Small-compound enhancers for functional O-mannosylation of alpha-dystroglycan, and uses thereof Wu, Xiao Hua (US) 2019-03-05 US disclosed
US-10221168-B1 Small-compound enhancers for functional O-mannosylation of alpha-dystroglycan, and uses thereof Wu, Xiao Hua (US) 2019-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10221168-B1 Small-compound enhancers for functional O-mannosylation of alpha-dystroglycan, and uses thereof MAN2A1, MAN1B1, ALG1 SCN4A 1286/4885SCN9A 1447/4885KDM4E 1758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.